Novavax Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Novavax Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Novavax Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Novavax Inc. is NVAX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Novavax Inc. has its primary listing on NASDAQ. You can trade Novavax Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Novavax Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Novavax Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Novavax Inc..